Table 1.
Mutation | Link to mitochondria | Links with PD |
---|---|---|
α-synuclein | Targeted to IMM and causes CI inhibition | (i) Major component of LBs (ii) Mutation linked with PD |
Parkin | Suggested role in mitochondrial function and antioxidant protection | Mutation linked to autosomal recessive juvenile PD |
PINK1 | Interaction with Parkin | Loss of kinase mutation linked to familial PD |
DJ-1 | (i) Antioxidant present in mitochondria (ii) Rescues mitochondria from PINK1 deletion |
Mutation linked with numerous cases of familial PD |
Omi/Hrta2 | (i) Mitochondrial location (ii) Interaction with PINK1 |
Loss of function mutations found in PD patients |
LRRK2 | (i) Protects against mitochondrial CI toxin rotenone (ii) Increases Parkin mediated cell protection (iii) Located in outer mitochondrial membrane |
Mutation linked with autosomal dominant PD |
ATP13A2 | Leads to lysosomal dysfunction and build up of α-synuclein which is toxic to CI | Mutation linked with hereditary form of PD |
PLA2G6 | (i) Located in mitochondria (ii) Protect mitochondria against oxidative stress |
Mutations linked to neurodegeneration and recently PD |
TFAM | (i) Regulates transcription of mtDNA (ii) Knockout mouse has respiratory chain deficiency |
(i) Knockout mouse develops PD phenotype (ii) Mutations in some variants give increased risk of PD |
POLG1 | (i) Involved in the synthesis and regulation of mtDNA (ii) Linked to respiratory chain deficiency in PD |
Mutation linked with PD |